November 2015 FDA Recall Drug by Mylan Institutional, Inc. (d.b.a. Udl Laboratories) (D-0235-2016 - Failed Impurities/Degradation Specifications)

This Class III drug recall was voluntarily initiated by Mylan Institutional, Inc. (d.b.a. Udl Laboratories) on November 2, 2015 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0235-2016

Reason for Recall
Failed Impurities/Degradation Specifications: Out of specification for impurities.
Initiated
11-02-2015
Reported
11-25-2015
Quantity
4,609 Packages

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
US Nationwide including Puerto Rico
Meclizine Hydrochloride Tablets, USP, 25 mg Tablets, Packaged in 10 x 10 Tablet Blister Pack Packages, Rx Only. Manufactured by: Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977. Mylan. NDC: 51079-090-20.

Batch or Lot Expiration Information

Lot# : 3060153, Expiry: 08/31/16